|
1
|
Wang CW and Klionsky DJ: The molecular
mechanism of autophagy. Mol Med. 9:65–76. 2003.
|
|
2
|
Levine B and Klionsky DJ: Development by
self-digestion: molecular mechanism and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Høyer-Hansen M and Jäättelä M:
AMP-activated protein kinase: a universal regulator of autophagy?
Autophagy. 3:381–383. 2007.PubMed/NCBI
|
|
4
|
Meijer AJ and Codogno P: Signalling and
autophagy regulation in health, aging and disease. Mol Aspects Med.
27:411–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abedin MJ, Wang D, McDonnell MA, Lehmann U
and Kelekar A: Autophagy delays apoptotic death in breast cancer
cells following DNA damage. Cell Death Differ. 14:500–510. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carew JS, Nawrocki ST, Kahue CN, Zhang H,
Yang C, Chung L, Houghton JA, Huang P, Giles FJ and Cleveland JL:
Targeting autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cuervo AM: Autophagy: in sickness and in
health. Trends Cell Biol. 14:70–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohsumi Y: Molecular dissection of
autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol.
2:211–216. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang XH, Yu J, Brown K and Levine B:
Beclin 1 contains a leucine-rich nuclear export signal that is
required for its autophagy and tumor suppressor function. Cancer
Res. 61:3443–3449. 2001.PubMed/NCBI
|
|
12
|
Maiuri MC, Le Toumelin G, Criollo A, Rain
JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K,
Tavernarakis N, Hickman JA, Geneste O and Kroemer G: Functional and
physical interaction between Bcl-X(L) and a BH3-like domain in
Beclin-1. EMBO J. 26:2527–2539. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu CT, Zhu J and Dagda R: Beclin
1-independent pathway of damage-induced mitophagy and autophagic
stress: implications for neurodegeneration and cell death.
Autophagy. 3:663–666. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meijer AJ and Codogno P: Regulation and
role of autophagy in mammalian cells. Int J Biochem Cell Biol.
36:2445–2462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hay N: The Akt-mTOR tango and its
relevance to cancer. Cancer Cell. 8:179–183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lum JJ, Bauer DE, Kong M, Harris MH, Li C,
Lindsten T and Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell. 120:237–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shaw RJ: LKB1 and AMP-activated protein
kinase control of mTOR signalling and growth. Acta Physiol (Oxf).
196:65–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Riley PA: Free radicals in biology:
oxidative stress and the effects of ionizing radiation. Int J
Radiat Biol. 65:27–33. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balaban RS, Nemoto S and Finkel T:
Mitochondria, oxidants, and aging. Cell. 120:483–495. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laurent A, Nicco C, Chereau C, Goulvestre
C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O,
Weil B and Batteux F: Controlling tumor growth by modulating
endogenous production of reactive oxygen species. Cancer Res.
65:948–956. 2005.PubMed/NCBI
|
|
22
|
Valencia A and Morán J: Reactive oxygen
species induce different cell death mechanisms in cultured neurons.
Free Radic Biol Med. 36:1112–1125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trachootham D, Zhou Y, Zhang H, Demizu Y,
Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J and
Huang P: Selective killing of oncogenically transformed cells
through a ROS mediated mechanism by beta-phenylethyl
isothiocyanate. Cancer Cell. 10:241–252. 2006. View Article : Google Scholar
|
|
24
|
Trachootham D, Zhang H, Zhang W, Feng L,
Du M, Zhou Y, Chen Z, Pelicano H, Plunkett W, Wierda WG, Keating MJ
and Huang P: Effective elimination of fludarabine-resistant CLL
cells by PEITC through a redox-mediated mechanism. Blood.
112:1912–1922. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thapa P, Karki R, Yoo HY, Park PH, Lee E,
Jeon KH, Na Y, Cho WJ, Kwon Y and Lee ES:
2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and
2,4-diaryl-5,6-dihydrothieno[2,3-h] quinoline derivatives for
topoisomerase I and II inhibitory activity, cytotoxicity, and
structure-activity relationship study. Bioorg Chem. 40:67–78.
2012.PubMed/NCBI
|
|
26
|
Muñoz A, Sojo F, Arenas DR, Kouznetsov VV
and Arvelo F: Cytotoxic effects of new
trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their
interaction with antitumoral drugs gemcitabine and paclitaxel on
cellular lines of human breast cancer. Chem Biol Interact.
189:215–221. 2011.
|
|
27
|
Metwally K, Aly O, Aly E, Banerjee A,
Ravindra R and Bane S: Synthesis and biological activity of
2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives.
Bioorg Med Chem. 15:2434–2440. 2007.PubMed/NCBI
|
|
28
|
Liu B, Cheng Y, Liu Q, Bao JK and Yang JM:
Autophagic pathways as new targets for cancer drug development.
Acta Pharmacol Sin. 31:1154–1164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ertmer A, Huber V, Gilch S, Yoshimori T,
Erfle V, Duyster J, Elsässer HP and Schätzl HM: The anticancer drug
imatinib induces cellular autophagy. Leukemia. 21:936–942.
2007.PubMed/NCBI
|
|
30
|
Marks PA: Discovery and development of
SAHA as an anticancer agent. Oncogene. 26:1351–1356. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Younes A: Therapeutic activity of
mTOR-inhibitors in mantle cell lymphoma: clues but no clear
answers. Autophagy. 4:707–709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim KW, Hwang M, Moretti L, Jaboin JJ, Cha
YI and Lu B: Autophagy upregulation by inhibitors of caspase-3 and
mTOR enhances radiotherapy in a mouse model of lung cancer.
Autophagy. 4:659–668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou F, Yang Y and Xing D: Bcl-2 and
Bcl-xL play important roles in the crosstalk between autophagy and
apoptosis. FEBS J. 278:403–413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sasi N, Hwang M, Jaboin J, Csiki I and Lu
B: Regulated cell death pathways: new twists in modulation of BCL2
family function. Mol Cancer Ther. 8:1421–1429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Walensky LD: BCL-2 in the crosshairs:
tipping the balance of life and death. Cell Death Differ.
13:1339–1350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shimizu S, Kanaseki T, Mizushima N, Mizuta
T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2
family proteins in a non-apoptotic programmed cell death dependent
on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pattingre S, Tassa A, Qu X, Garuti R,
Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2
antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Noble CG, Dong JM, Manser E and Song H:
Bcl-xL and UVRAG cause a monomer-dimer switch in Beclin1. J Biol
Chem. 283:26274–26282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferri KF and Kroemer G: Organelle-specific
initiation of cell death pathways. Nat Cell Biol. 3:E255–E263.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rodriguez-Enriquez S, He L and Lemasters
JJ: Role of mitochondrial permeability transition pores in
mitochondrial autophagy. Int J Biochem Cell Biol. 36:2463–2472.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Høyer-Hansen M, Bastholm L, Szyniarowski
P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N,
Elling F, Rizzuto R, Mathiasen IS and Jäättelä M: Control of
macroautophagy by calcium, calmodulin-dependent kinase kinase-beta,
and Bcl-2. Mol Cell. 25:193–205. 2007.PubMed/NCBI
|
|
43
|
Manning BD, Tee AR, Logsdon MN, Blenis J
and Cantley LC: Identification of the tuberous sclerosis complex-2
tumor suppressor gene product tuberin as a target of the
phosphoinositide 3-kinase/akt pathway. Mol Cell. 10:151–162. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Inoki K, Li Y, Zhu T, Wu J and Guan KL:
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR
signaling. Nat Cell Biol. 4:648–657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schumacker PT: Reactive oxygen species in
cancer cells: live by the sword, die by the sword. Cancer Cell.
10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pan JS, Hong MZ and Ren JL: Reactive
oxygen species: a double-edged sword in oncogenesis. World J
Gastroenterol. 15:1702–1707. 2009. View Article : Google Scholar : PubMed/NCBI
|
